Laventi Groupsp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-02-15
Share capital
5,000.00 PLN
Registered address
ul. Konduktorska 33, 40-155 Katowice, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 322 days for 2024).

  • 2025not filed
  • 202402/06/2026
  • 202330/09/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 56.35kMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD 2.57kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 48.61kMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 25.93kMedianUSD 118.27kAverageUSD 1.54m

Authorized Representatives

Przemysław Piotr Szczępowicz – Management Board Member
Robert Roman Romanow – Management Board Member

Manner of representation

Each member of the management board independently is authorized to represent the company and to perform legal acts on its behalf.

Ownership

OwnerSharesShare valueStake
Robert Roman Romanówage 55
49$661.8049%
Przemysław Piotr Szczępowiczage 48
49$661.8049%
Others
2$27.012%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-06-27.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,578
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$656

Competitors

Name
Natur DayS.A.
Biotriosp. z o.o.
Nature's Voicesp. z o.o.
Pexon Polandsp. z o.o.
Munar PharmaS.A.
BIO Animalisp. z o.o.
Ampliconsp. z o.o.
Xenira Pharmaceuticalssp. z o.o.
Bioresearch PharmaS.A.
Grupa FinepharmS.A.

FAQ

Last updated: 2026-06-03